Last reviewed · How we verify
Chronic Migraine
Approved treatments
- Botox · Allergan
BOTOX blocks neuromuscular transmission by inhibiting acetylcholine release through cleavage of SNAP-25. - PF-07976016 Formulation A · Pfizer
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic Migraine patent landscape — cliff calendar, originator estates, attackable patents
- Chronic Migraine treatment landscape brief
- Chronic Migraine treatment updates RSS
Frequently asked questions about Chronic Migraine
What drugs treat Chronic Migraine?
Tracked treatments include Botox, PF-07976016 Formulation A.
What is the treatment for Chronic Migraine?
Standard treatment for Chronic Migraine includes Botox, PF-07976016 Formulation A. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic Migraine patent cliff · Chronic Migraine CI report
- Treatment: Botox · Allergan
- Treatment: PF-07976016 Formulation A · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing